Strides Pharma Secures USFDA Nod For triglyceride Tamer Icosapent

Strides Pharma Science Ltd said that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, has gained US Food and Drug Administration (USFDA) certification for its icosapent ethyl capsules in both 0.5 gram and 1 gram forms. High...

Katalin Kariko, Drew Weissman Secures Nobel Prize For Medicine

Katalin Kariko and Drew Weissman were awarded the Nobel Prize in Medicine for their work on messenger RNA (mRNA) technology, which cleared the door for the ground-breaking Covid-19 vaccines. The pair, who had been tipped as favourites...

EMA Approves Geron's MAA For Imetelstat To Treat Myelodysplastic syndromes

Geron Corporation, a late-stage clinical biopharmaceutical company, announced that the European Medicines Agency (EMA) has approved imetelstat, a first-in-class investigational telomerase inhibitor, for the treatment of transfusion-dependent...

Biogen's Tofidence Bags US FDA Approval To Treat Rheumatoid Arthritis

Tofidence (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing Actemra, has been authorized by the US Food and Drug Administration (FDA). The intravenous formulation of Tofidence has been authorized for the...

IQuest Enterprises To Acquire Active Pharma

IQuest Enterprises, a multi-sector investment group, will purchase Viatris' active pharmaceutical ingredients (API) business in India for an undisclosed sum. As per IQuest Enterprises, the investment firm has entered into a binding deal to acquire...

Novo, Torrent To Expand Partnership

As per top corporate executive, Novo Nordisk India Pvt. Ltd, the local affiliate of Danish pharmaceutical multinational Novo Nordisk, is in early talks with Torrent Pharmaceuticals Ltd to expand their manufacturing relationship...

SGC & HitGen Sign Research collaboration For Drug Discovery

HitGen Inc. established a collaboration with The Structural Genomics Consortium (SGC), a public-private partnership dedicated to the development of novel therapeutics through open-access research. HitGen will evaluate under-represented targets...

BDR Pharma Unveils Zisavel To Treat Invasive Aspergillosis & Mucormycosis

BDR Pharmaceutical, a major pharmaceutical business, has announced the introduction of Zisavel capsules, the first-of-its-kind generic medicine for the treatment of invasive aspergillosis and mucormycosis. Zisavel belongs to the isavuconazole...

US FDA Approves Ryzumvl, Medicine To Treat Mydriasis

The FDA has approved Ryzumvi (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis caused by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide). Ryzumvl is projected to...

Integrating Biosimilars into Chronic Disease Treatment Plans

Biosimilars, akin to their originator biologics, offer a promising avenue for addressing the complex needs of individuals battling chronic illnesses

© 2024 India Pharma Outlook. All Rights Reserved.